Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAxsome Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 7 | -$2.14 | -$0.92 | -$1.35 |
| Q2 2025 | 13 | -$1.20 | -$0.73 | -$1.06 |
| Q3 2025 | 12 | -$1.11 | -$0.57 | -$0.86 |
| Q4 2025 | 12 | -$0.89 | -$0.39 | -$0.56 |
| Q1 2026 | 6 | -$0.72 | -$0.47 | -$0.63 |
| Q2 2026 | 3 | -$0.18 | -$0.16 | -$0.17 |
| Q3 2026 | 3 | $0.22 | $0.25 | $0.23 |
| Q4 2026 | 3 | $0.73 | $0.83 | $0.78 |
| Q1 2027 | 2 | $1.48 | $1.70 | $1.59 |
| Q2 2027 | 2 | $2.03 | $2.32 | $2.18 |
| Q3 2027 | 2 | $2.47 | $2.83 | $2.65 |
| Q4 2027 | 2 | $3.04 | $3.48 | $3.27 |
Axsome Therapeutics, Inc. Earnings Date And Information
Axsome Therapeutics, Inc. last posted its earnings results on Monday, November 3rd, 2025. The company reported $-0.94 earnings per share for the quarter, missing analysts' consensus estimates of $-0.82 by $0.12. The company had revenue of 170.99 M for the quarter and had revenue of 385.69 M for the year. Axsome Therapeutics, Inc. has generated $-6 earnings per share over the last year ($-5.99 diluted earnings per share) and currently has a price-to-earnings ratio of -32.26. Axsome Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 17th, 2026 based on prior year's report dates.
Axsome Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/03/2025 | Q3 2025 | -$0.82 | -$0.94 | -0.12 | $162.67 M | $170.99 M |
| 08/04/2025 | Q2 2025 | -$1.00 | -$0.97 | 0.03 | $138.02 M | $150.04 M |
| 05/05/2025 | Q1 2025 | -$1.26 | -$1.22 | 0.04 | N/A | $121.46 M |
| 02/18/2025 | Q4 2024 | -$1.00 | -$1.54 | -0.54 | N/A | $118.77 M |
| 11/12/2024 | Q3 2024 | -$1.38 | -$1.34 | 0.04 | $98.37 M | $104.76 M |
| 08/05/2024 | Q2 2024 | -$1.30 | -$1.67 | -0.37 | $86.92 M | $87.17 M |
| 05/06/2024 | Q1 2024 | -$1.20 | -$1.44 | -0.24 | N/A | $75.00 M |
| 02/23/2024 | Q4 2023 | N/A | -$2.08 | N/A | N/A | $71.53 M |
| 11/06/2023 | Q3 2023 | -$1.24 | -$1.32 | -0.08 | $54.87 M | $57.79 M |
| 08/07/2023 | Q2 2023 | -$1.24 | -$1.54 | -0.3 | $40.88 M | $46.70 M |
| 05/08/2023 | Q1 2023 | N/A | -$0.26 | N/A | $25.47 M | $94.58 M |
| 02/27/2023 | Q4 2022 | N/A | -$1.41 | N/A | $21.75 M | $24.37 M |
| 11/07/2022 | Q3 2022 | -$1.10 | -$1.07 | 0.03 | $16.64 M | $16.85 M |
| 08/09/2022 | Q2 2022 | -$1.19 | -$1.06 | 0.13 | $6.92 M | $8.82 M |
| 05/02/2022 | Q1 2022 | -$1.02 | -$1.03 | -0.01 | N/A | $0 |
| 03/01/2022 | Q4 2021 | -$0.99 | -$0.90 | 0.09 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.94 | -$0.93 | 0.01 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$0.88 | -$0.86 | 0.02 | N/A | $0 |
| 05/10/2021 | Q1 2021 | -$0.83 | -$0.78 | 0.05 | N/A | $0 |
| 03/01/2021 | Q4 2020 | -$0.73 | -$0.78 | -0.05 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Axsome Therapeutics, Inc. Earnings: FAQ's
Axsome Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 17th, 2026 based offlast year's report dates.
The conference call for Axsome Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Axsome Therapeutics, Inc.'s latest earnings report can be read online.
Axsome Therapeutics, Inc. (:AXSM) has a recorded annual revenue of $385.69 M.
Axsome Therapeutics, Inc. (:AXSM) has a recorded net income of $-287,216,000.Axsome Therapeutics, Inc. has generated $-5.99 earnings per share over the last four quarters.
Axsome Therapeutics, Inc. (:AXSM) has a price-to-earnings ratio of -32.26 and price/earnings-to-growth ratio is -4.09.